Legault, Kimberly
Blostein, Mark
Carrier, Marc
Kahn, Susan
Schulman, Sam
Shivakumar, Sudeep
Wu, Cynthia
Crowther, Mark A.
Funding for this research was provided by:
Heart and Stroke Foundation of Canada (G-13-0002011)
Article History
Received: 5 April 2019
Accepted: 3 April 2020
First Online: 25 April 2020
Change Date: 18 May 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Research ethics board approval for the study was obtained from each clinical site (Hamilton Integrated Research Ethics Board identifier for central site: #14-366). Written consent was obtained from each participant.
: Not applicable
: This study received support from Bayer. MB has received advisory board fees and research support from Bayer. MC has received research funding from BMS and Leo Pharma and honoraria from Pfizer, Bayer, Leo Pharma, and Sanofi. SK has received advisory board fees from BMS, Pfizer, Sanofi, and Aspen. S. Shivakumar has received honoraria from Bayer and Pfizer. CW has received advisory board fees for Leo pharma and Pfizer. KL, MAC, S. Schulman declared no additional COI.